Overview

Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

Status:
Completed
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety of inhaled carbon monoxide (iCO) in intubated patients with sepsis-induced ARDS.
Phase:
Phase 1
Details
Lead Sponsor:
Brigham and Women's Hospital
Weill Medical College of Cornell University
Collaborators:
Brigham and Women's Hospital
Duke University
Massachusetts General Hospital
Weill Medical College of Cornell University
Treatments:
Carbon Monoxide